Treatment considerations in Helicobacter pylori management
Aliment Pharmacol Ther
.
2022 Jan:55 Suppl 1:S22-S28.
doi: 10.1111/apt.16652.
Authors
Jyh-Chin Yang
1
,
John Y Kao
2
Affiliations
1
Departments of Internal Medicine, Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan.
2
Division of Gastroenterology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
PMID:
34989432
DOI:
10.1111/apt.16652
No abstract available
MeSH terms
Anti-Bacterial Agents / therapeutic use
Helicobacter Infections* / drug therapy
Helicobacter pylori*
Humans
Substances
Anti-Bacterial Agents